Novo Nordisk A/Sthe Danish manufacturer of blockbuster obesity drugs Ozempic and Wegovy, is planning a “mega manufacturing facility” outside of Dublin in a bid to keep up with soaring demand.
The pharmaceutical giant has applied to build a campus covering 147,192 square meters (1.6 million square feet) in Clondalkin which would create up to 1,100 jobs in the region, according to reporting by the Sunday Times which cites detailed documents submitted with the planning application.